Results from the VOYAGER PAD Trial reported

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes…

Can seniors handle results of Alzheimer’s risk tests?

(HealthDay)—As researchers hone in on ways to detect whether someone has a high risk of developing Alzheimer’s disease before they have any symptoms, mental health professionals have worried what the psychological fallout of that knowledge might be. But new research suggests that people can handle the truth. In the study,…